Zhang, Lifang
Luo, Ge
Wang, Haiying
Lou, Honggang
Yan, Min
Funding for this research was provided by:
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Article History
Received: 14 February 2026
Accepted: 12 June 2026
First Online: 20 June 2026
Declarations
:
: The study was approved by the Drug Clinical Trial Ethics Committee of the Second Affiliated Hospital, Zhejiang University School of Medicine. The study was conducted in accordance with local legislation and institutional requirements. Written informed consent was obtained from all participants prior to enrollment.
: Min Yan reports receiving research grants from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Other authors declare that they have no competing interests.
: Min Yan reports receiving research grants from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Other authors declare that they have no competing interests.